Improvement of Knowledge About the Arthrogenic Muscle Inhibition in the Aftermath of Knee Trauma.

Anterior Cruciate Ligament Rupture Clinical Trial

— CAMIK  

Official title:

Contribution of Functional Brain MRI to the Understanding of Arthrogenic Muscle Inhibition (AMI) in the Aftermath of Knee Trauma.

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03950024
• Other study ID #: RC31/19/0029
• Secondary ID: 2019-A00479-48
• Status: Recruiting
• Phase: N/A
• Start date: October 29, 2019
• Est. completion date: December 2023

Study information

• Verified date: January 2023
• Source: University Hospital, Toulouse
• Contact: Etienne CAVAIGNAC, MD
• Phone: +33 5 61 77 55 81
• Email: cavaignac.e[@]chu-toulouse.fr
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Arthrogenic Muscle Inhibition (AMI) is one of the classic complications occurring in the aftermath of knee trauma; AMI is grossly defined as a lack of extension due to quadriceps inhibition and hamstring contracture. However, its origins remains unknown with a strong suspicion for a central brain origin. It could be the missing link explaining this lack of extension following an anterior cruciate ligament (ACL) rupture. The primary hypothesis of this study is that a difference in activation of motor brain areas exists in patients with an ACL rupture, between those with AMI or without. The second hypothesis is that this difference could be seen on brain functional MRI.

Description:

AMI leads to quadriceps atrophy, persistent knee pain, dynamic instability, and a higher rate of osteoarthritis. A recent literature review suggests that the AMI phenomenon is multifactorial, but not widely known and poorly understood. Known mechanisms include impaired motor function at rest, impaired transmission of information from joint sensory receptors, impaired excitability of the spinal reflex and impaired cortical activity. Several studies have suggested a link between ACL rupture and central nervous system reorganization. Among the neurophysiological investigations explored are the evoked somesthesic potentials, electroencephalography, and transcranial magnetic stimulation (TMS). However, these mechanisms alone do not explain the phenomenon in its entirety, suggesting that there are other mechanisms. Furthermore, no study has used functional brain MRI to assess the existence of similar changes in AMI. This study plans to compare two groups of patients with an ACL rupture: a group with AMI, and a group without AMI. Both groups will undergo a functional brain MRI in order to analyse any modification of the sensory-motor network connectivity that could occur.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 40
• Est. completion date: December 2023
• Est. primary completion date: December 2023
• Accepts healthy volunteers: No
• Gender: Male
• Age group: 20 Years to 30 Years

Eligibility

Inclusion Criteria:

• male patient, right-handed,
• with a severe right knee sprain in the event of ACL rupture,
• occurrence of trauma within 4 weeks prior to inclusion,
• with a score of = 8/10 on the Edinburgh Manual Laterality Questionnaire, -affiliated or benefiting from public health services.

Exclusion Criteria:

• person presenting any of these conditions : professional player / athlete, -contraindication to the MRI examination (claustrophobic patient, patient with a metallic element),
• patient already operated on with ligament damage to the knee other than ACL,
• patient with iterative ACL rupture,
• patient who has undergone contralateral ligament reconstruction,
• patient with multi-ligamentary knee injury,
• patient refusing to be informed of any abnormality detected on brain MRI, -protected patient (adults under guardianship or other legal protection, deprived of their liberty by judicial or administrative decision).

Related Conditions & MeSH terms

• Anterior Cruciate Ligament Rupture
• Rupture

Intervention

Diagnostic Test:
• functional brain MRI
The functional brain MRI realized will be a examination with a resting sequence and a sequence during a movement imagination task. (knee bent)

Locations

Country	Name	City	State
France	Pierre Paul Riquet Hospital	Toulouse	Occitanie

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Toulouse

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Matrix of correlation coefficients	A matrix of correlation coefficients, measured by MRI, representing the strength of the sensory-motor network connectivity at rest for each group.	Day 0
Secondary	Activation map of the motor representations of knee movement	An activation map of the motor representations of knee movement are measured by MRI	Day 0